SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-036274
Filing Date
2023-06-12
Accepted
2023-06-12 16:17:18
Documents
2
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1618
2 POA DOCUMENT poa.txt EX-24 3647
  Complete submission text file 0001209191-23-036274.txt   6675
Mailing Address C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Molineaux Susan (Reporting) CIK: 0001553389 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39335 | Film No.: 231008301

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Issuer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations